Jay Peredo

peptide connoisseur @peptracker | prev many places, many things (2x exits)

[Jay Peredo @jayperedox]

100 ratings on the US App Store today! 🫡

[Jay Peredo @jayperedox]

@brettcalhounn submitted @PepTracker’s pitch a couple weeks ago! would love to chat.

[Jay Peredo @jayperedox]

retatrutide WILL become the #1 selling drug in the world.

[Bryan Johnson @bryan_johnson]

These numbers are shocking. It's like we got a new frontier AI model but for the body.

Lilly's phase 3 results for retatrutide:

> highest dose lost 28.3% of body weight in 80 wks
> 70 lbs ave
> 45% lost 30% or more of their body weight
> 65% on the top dose no longer clinically obese

Retatrutide is more dynamic than semaglutide and tirzepatide because it targets three receptors (GIP, GLP-1, and glucagon), versus one and two, respectively.

Side effects, on the highest dose (12mg), were higher for retatrutide than tirzepatide (nausea and GI), with an 11.3% drop out rate. The lowest 4mg dose still delivered 19% loss with fewer dropouts than placebo.

[Jay Peredo @jayperedox]

@andrewchen let's go - submitted @PepTracker's application 💉

[Jay Peredo @jayperedox]

@alexxgrowth damn would be interested in learning more! i’ve tried another platform and it just didn’t work for my app

[Jay Peredo @jayperedox]

@TheCryptoDaddi reta, mots-c, and klow

[Jay Peredo @jayperedox]

back on retatrutide after a 4 week break 💪

[Jay Peredo @jayperedox]

@cormachayden_ insane. happening for me too w/ @PepTracker. so much ai slop peptide apps now…

[Jay Peredo @jayperedox]

@nikillinit that’s why we’re building the adherence layer for peptides + glps @PepTracker. would love to chat. already working with functional health clinics on this exact problem.

[Jay Peredo @jayperedox]

@KevinPicchi VC

[Jay Peredo @jayperedox]

@m_goes_distance sending you a dm sir 🫡

building the adherence layer for peptides @peptracker

growing organically and starting to see real pull from clinics around adherence + outcomes

[PepTracker App @PepTracker]

RFK has been saying this was coming for weeks. Now it’s official.

The FDA is removing 12 peptides from the restricted list. BPC-157, MOTS-c, Semax, Epitalon, Thymosin beta-4 among them. Independent scientific review begins in July.

People have been sourcing these through grey markets for years because legitimate access was cut off. That’s what created real risk for real people.

This should never have happened in the first place.

[Jay Peredo @jayperedox]

@maxmarchione not the cheap amazon syringes 😅

[Jay Peredo @jayperedox]

@alexolim_ Hooks

[Jay Peredo @jayperedox]

@AbudBakri happens to all of our accounts…the unfortunate cycle.

make a new account, get traction, banned, repeat 😬

[PepTracker App @PepTracker]

GLP-1s are doing a lot more than suppressing appetite and the data reflects that.

This is why tracking your protocol matters.

[PepTracker App @PepTracker]

Eli Lilly's orforglipron just got approved as the first GLP-1 pill for weight loss.

A lot of people who passed on injections are about to reconsider.

The barrier to entry just got a lot lower.

[PepTracker App @PepTracker]

The FDA is expected to lift its ban on injectable peptides from compounding pharmacies.

The regulatory tide is finally shifting.

[Jay Peredo @jayperedox]

@superham hmmm 👀

[Jay Peredo @jayperedox]

Imagine actually buying your bac water from Amazon in the first place 😅

[Jay Peredo @jayperedox]

@maxmarchione send me one plssss